A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib

Clinical trial NCT00570635 · COMPLETED

Trial details

NCT number: NCT00570635
Sponsor: Exelixis
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors Gastrointestinal Neoplasms

Start date: 2007-12-01
Primary completion: 2009-05-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.